Inhibrx Biosciences, Inc. (INBX)

NASDAQ: INBX · Real-Time Price · USD

80.36

+2.28 (2.92%)

At close: Dec 24, 2025, 1:00 PM EST

81.29

+0.93 (1.16%)

After-hours: Dec 24, 2025, 4:40 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Biologic Therapeutics	1.80M	Log In
Biologic Therapeutics Growth	-17.88%	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.